ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1808

Increased Frequency of Obstructive Sleep Apnea Syndrome in Behcet’s Syndrome Patients with Vena Cava Superior Thrombosis

Aycan Gokturk1, Sinem Nihal Esatoglu1, Yesim Ozguler1, Ersan Atahan2, Benan Musellim2, Vedat Hamuryudan1, Hasan Yazici3 and Emire Seyahi1, 1Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, 2Istanbul University, Cerrahpasa Medical Faculty, Department of Pulmonary Medicine, Istanbul, Turkey, 3Istanbul Academic Hospital, Istanbul, Turkey

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Behcet's syndrome and thrombosis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, October 22, 2018

Title: Vasculitis Poster II: Behҫet’s Disease and IgG4-Related Disease

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Superior vena cava syndrome (SVCS), is a medical emergency and can also be seen in Behçet’s syndrome (BS). Contrary to the severe outcome seen in malign conditions, SVCS in BS usually has a benign course, complicated rarely by hemoptysis, pleural effusion and a chylothorax. We had noted that BS patients with SVCS frequently complained of sleep disturbances, snoring and sleep apnea, suggesting an obstructive sleep apnea (OSA) disorder. We formally surveyed the degree of risk for OSA among BS patients with SVCS and suitable controls using the Berlin questionnaire, a screening questionnaire for OSA with a high sensitivity and modest specificity (1). Methods: Because of the lower frequency of female patients with VCSS (n= 2), only males were included. We studied 28 BS patients with SVCS (Group 1), 80 BS patients with vascular involvement without a SVCS (Group 2), and 59 BS patients with no vascular involvement (Group 3). Also 80 apparently healthy individuals (Group 4) of similar age and gender to BS patients were studied. The Berlin questionnaire was used to assess risk of OSA (1). Polysomnography was performed in patients at high risk for OSA according to the Berlin questionnaire. Results: There were no differences regarding demographic characteristics, disease duration and variables associated with OSA among the groups (Table). The Berlin questionnaire categorized 57.1 % (16/28) of the BS patients with SVCS (Group 1) as having a high risk for OSA and this was significantly higher compared to that found in the control groups. The frequency of those at high risk for OSA was 15 %, 8.5 %, 11.3 % in Group 2, 3 and 4, respectively (p>0.05). Until now, polysomnography was performed in 12 subjects (5 patients with SVCS, 1 patient with vascular involvement without a SVCS and 6 healthy controls). OSA was detected in 3/5 patients with SVCS and 1/1 patient with vascular involvement without a SVCS and 4/6 healthy controls. Conclusion: This study shows that BS patients with a history of VCSS are at high risk of OSA. This is probably due to the external pressure of the significant venous collaterals on the upper airways. Reference: 1: Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med. 1999 Oct 5;131(7):485-91

Table. Demographic characteristics and variables associated with obstructive sleep apnea  
  Group 1  (BS patients with SVCS) (n=28) Group 2 (BS patients with vascular involvement without SVCS) (n=80) Group 3  (BS patients with no vascular involvement) (n=59) Group 4 (Healthy controls) (n=80) p value
Age, mean ± SD, years

44.3 ± 9.7

42. 1 ± 7.8

41.9 ± 5.9

42.7 ± 9.7

0.051
Disease duration, mean ± SD, years

18.7 ± 9.4

14.6 ± 7.7

12.5 ± 6.5

 

0.001
Hypertension, n (%) 4 (14.3) 6 (7.5) 2 (3.4) 4(5) NS
BMI, mean ± SD

26.8 ± 4.7

26.4 ± 3.9

26.2 ± 3.3

27.0 ± 3.5

NS

High risk for OSA, n (%) 16 (57.1) 12 (15) 5 (8.5) 9 (11.3) < 0,001
      

 


Disclosure: A. Gokturk, None; S. N. Esatoglu, None; Y. Ozguler, None; E. Atahan, None; B. Musellim, None; V. Hamuryudan, None; H. Yazici, None; E. Seyahi, None.

To cite this abstract in AMA style:

Gokturk A, Esatoglu SN, Ozguler Y, Atahan E, Musellim B, Hamuryudan V, Yazici H, Seyahi E. Increased Frequency of Obstructive Sleep Apnea Syndrome in Behcet’s Syndrome Patients with Vena Cava Superior Thrombosis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/increased-frequency-of-obstructive-sleep-apnea-syndrome-in-behcets-syndrome-patients-with-vena-cava-superior-thrombosis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increased-frequency-of-obstructive-sleep-apnea-syndrome-in-behcets-syndrome-patients-with-vena-cava-superior-thrombosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology